Position
Sovran Advisors, LLC in AbbVie Inc.
Back to the book · All holders of ABBV
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$37.4K$216.74 → $211.32
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 6.9K | $1.5M | — | — | — | 0.1% |
| Q1 2026 | 7.08K | $1.5M | $211.32 | −$37.4K | $37.4K | 0.1% |